Sign Up
Stories
Concr: Astrophysics-Driven Healthtech
Share
4P-Pharma Secures €15 Million Funding
AI Cancer Diagnostics Collaboration
AI Partnerships Drive Drug Discovery
AGO Recognition Boosts BluePrint® Impact
BenevolentAI's Shareholder Letter 2023
Bioptimus Launches AI Startup for Biotec...
Overview
API
Concr, a healthtech startup, receives a £200k seed investment from Debiopharm Innovation Fund to address the data problem in drug development using astrophysics. The company has formed partnerships with Roche and Step Pharma, and its technology has garnered interest from pharmaceutical companies.
Ask a question
How might Concr's integration of astrophysics influence the future of drug development?
How might Concr's partnerships with Roche and Step Pharma impact the pharmaceutical industry?
What are the potential implications of Debiopharm's investment strategy for the precision medicine field?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Aug 2023
Sep 2023
Oct 2023
Coverage